Disclosures for "Using Qualitative Interviews to Improve Quantitative Assessments of Quality of Life in Patients with Neurofibromatosis 2")
-
Ms. Von Imhof has nothing to disclose.
-
Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
-
Dr. Nghiemphu has received research support from Erasca. Dr. Nghiemphu has received research support from Springswork. Dr. Nghiemphu has received research support from Children's Tumor Foundation. Dr. Nghiemphu has received research support from NIH-NCI . Dr. Nghiemphu has received research support from Genentech. Dr. Nghiemphu has received research support from DOD. Dr. Nghiemphu has received research support from Millenium. Dr. Nghiemphu has received research support from GCAR. Dr. Nghiemphu has received research support from Novartis. Dr. Nghiemphu has received research support from BMS. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving as a advisory board with Alexion.
-
Dr. Babovic-Vuksanovic has received personal compensation for serving as an employee of AstraZeneka. Dr. Babovic-Vuksanovic has received personal compensation for serving as an employee of Alexion. Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Babovic-Vuksanovic has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca . Dr. Babovic-Vuksanovic has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Loeb&Loeb. The institution of Dr. Babovic-Vuksanovic has received research support from DOD. Dr. Babovic-Vuksanovic has received publishing royalties from a publication relating to health care.
-
The institution of Vanessa Merker has received research support from Children's tumor foundation . The institution of Vanessa Merker has received research support from NF Northeast. Vanessa Merker has received personal compensation in the range of $10,000-$49,999 for serving as a science writer with Neurofibromatosis Network.